Release of tumor necrosis factor-α and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin
Background: The preventive effect of low-dose aspirin in cardiovascular disease is generally attributed to its antiplatelet action caused by differential inhibition of platelet cyclooxygenase-1. However, there is evidence that aspirin also affects release of inflammatory cytokines, including tumor n...
Saved in:
| Main Authors: | Ilse Beckmann, Shlomo Ben-Efraim, Monica Vervoort, Henk C. S. Wallenburg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2001-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1080/09629350120054554 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of prostanoids in regulatory T cells and their implications in inflammatory diseases and cancers
by: Somsak Prasongtanakij, et al.
Published: (2025-06-01) -
Alkylglycerol monooxygenase represses prostanoid biosynthesis in a sex-dependent manner
by: Zhigang Rao, et al.
Published: (2025-06-01) -
Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity
by: Shlomo Ben-Efraim
Published: (1992-01-01) -
Epigenetic Regulations of Inflammatory Cyclooxygenase-Derived Prostanoids: Molecular Basis and Pathophysiological Consequences
by: Hedi Harizi
Published: (2015-01-01) -
Advanced Subclinical Atherosclerosis and Low-Dose Aspirin
by: Michael J. Blaha, MD, MPH, et al.
Published: (2025-07-01)